Avanos Medical, Inc. (AVNS)

US — Healthcare Sector
Peers: AORT  ANIK  SGHT  OFIX  AXGN  SRDX  FNA  GKOS  KIDS  CNMD  LIVN  ITGR  TMCI  ESTA  NVRO  NUVA 

Automate Your Wheel Strategy on AVNS

With Tiblio's Option Bot, you can configure your own wheel strategy including AVNS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AVNS
  • Rev/Share 14.9501
  • Book/Share 18.2082
  • PB 0.6903
  • Debt/Equity 0.1679
  • CurrentRatio 2.5685
  • ROIC -0.3693

 

  • MktCap 581287080.0
  • FreeCF/Share 2.4729
  • PFCF 5.099
  • PE -1.5067
  • Debt/Assets 0.1272
  • DivYield 0
  • ROE -0.3734

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
AVNS
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Neutral

Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Read More
image for news Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
New Strong Sell Stocks for May 9th
AMPY, AVNS, BCC
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Negative

AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.

Read More
image for news New Strong Sell Stocks for May 9th
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
AVNS
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.

Read More
image for news AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
AVNS
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral

Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.

Read More
image for news Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
AVNS
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive

Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.

Read More
image for news Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
AVNS
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral

ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.

Read More
image for news Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
AVNS
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.

Read More
image for news AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
New Strong Sell Stocks for March 24th
AIRS, AMPH, AVNS
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative

AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.

Read More
image for news New Strong Sell Stocks for March 24th
New Strong Sell Stocks for March 18th
AVNS, CABO, CARS
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Negative

AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.

Read More
image for news New Strong Sell Stocks for March 18th
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
AVNS
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive

Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

Read More
image for news AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
AVNS
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call.

Read More
image for news Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
AVNS
Published: February 26, 2025 by: PRNewsWire
Sentiment: Neutral

ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results.

Read More
image for news Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
AVNS
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral

ALPHARETTA, Ga. , Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2024 on Wednesday, Feb. 26 at 9 a.m.

Read More
image for news Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results

About Avanos Medical, Inc. (AVNS)

  • IPO Date 2014-10-21
  • Website https://avanos.com
  • Industry Medical - Devices
  • CEO Mr. Sigfrido Delgado
  • Employees 2227

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.